The Competition Appellate Tribunal (CAT) upheld the ‘s (CCP) finding that Reckitt Benckiser Pakistan Limited engaged in deceptive marketing practices. The company was found guilty of disseminating misleading information about its product, Strepsils, which is registered as a food item and not a medicinal product for sore throat relief.
The Tribunal ordered Reckitt Benckiser to pay a penalty of Rs30 million and comply with the Commission’s corrective measures within the stipulated timeframe. The case was initiated by Square Distribution & Marketing System (Pvt.) Limited after alleging misleading advertising and marketing campaigns regarding Strepsils’ status and characteristics.
Following CCP proceedings, Reckitt Benckiser made significant changes to its product packaging and disclosures, prominently displaying “Non-Medicated” in both English and Urdu. The company is now required to publicize these changes through advertisements in widely circulated newspapers until full compliance is achieved.
Meezan Bank, Pakistan's premier Islamic bank, once again partnered with The Indus Hospital & Health…
Pakistan’s leading digital microfinance bank, Mobilink Bank, and Yango, part of the global technology company…
Pakistan’s freelancing market is rapidly emerging, and the export earnings of Pakistani freelancers are expected…
To celebrate the release of Atif Aslam’s highly anticipated new album, Subah Aye Na, Spotify…
KARACHI: Supernet Technologies Limited (STL) is looking to strengthen its working-capital capacity as a growing…
Master Changan Motors Limited (MCML), Pakistan’s No.1 new entrant and leading Chinese automotive brand, is…
This website uses cookies.
